Tag: Siegel
New York Valves hears 30-day results of low-profile TAVI valve
Thirty-day results of the US early feasibility study assessing the use of the Siegel (Mirus) 8Fr...
Early feasibility study of Siegel 8Fr TAVI valve launches
MiRus has announced the launch of the US multicentre early feasibility study (EFS) of the Siegel...
First-in-human results with Mirus Siegel TAVI valve presented at New York Valves 2024
Initial experience with the Siegel (Mirus) 8Fr transcatheter aortic valve implantation (TAVI) de...
